Mahalo | $2,600,000 | (Jun 26, 2025)
Elfie | $12,000,000 | (Jun 26, 2025)
AllSpice.io | $15,000,000 | (Jun 26, 2025)
Certified by Founder
Lodge
GC Therapeutics
start up
United States
- Cambridge, MA
- 24/09/2024
- Series A
- $65,000,000
GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cells fates in a single step and have validated cells for many applications. We have also developed SuperCells™ by tailoring cells for specific diseases.
The core technology of GCTx was conceived, invented and perfected in Professor George Church’s lab at Harvard Medical School. We are a group of passionate biologists and tissue engineers whose goal is to bring this breakthrough approach to patients.
- Industry Biotechnology Research
- Website https://www.gc-tx.com/
- LinkedIn https://www.linkedin.com/company/gctx/
Pro Athlete Community (PAC) | $7,600,000 | (Jun 26, 2025)
Kalshi | $185,000,000 | (Jun 26, 2025)
Armory | $1,511,654 | (Jun 26, 2025)
Obviant | $7,100,000 | (Jun 26, 2025)
Qunnect | $10,000,000 | (Jun 26, 2025)
Neuron23 | $96,500,000 | (Jun 26, 2025)
Digital Asset | $135,000,000 | (Jun 25, 2025)
Waltz | $50,000,000 | (Jun 25, 2025)
Blank Metal | $3,000,000 | (Jun 25, 2025)